DODFX
Price
$18.56
Change
+$0.16 (+0.87%)
Updated
Jun 2 closing price
Net Assets
65.21B
JPVRX
Price
$22.21
Change
+$0.08 (+0.36%)
Updated
Jun 2 closing price
Net Assets
3.63B
Interact to see
Advertisement

DODFX vs JPVRX

Header iconDODFX vs JPVRX Comparison
Open Charts DODFX vs JPVRXBanner chart's image
DODFX vs JPVRX Comparison Chart in %
View a ticker or compare two or three
VS
DODFX vs. JPVRX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DODFX is a Buy and JPVRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DODFX has more cash in the bank: 65.2B vs. JPVRX (3.63B). JPVRX pays higher dividends than DODFX: JPVRX (2.71) vs DODFX (2.20). DODFX was incepted earlier than JPVRX: DODFX (25 years) vs JPVRX (10 years). JPVRX (0.80) is less costly to investors than DODFX (0.61). JPVRX is a more actively managed with annual turnover of: 29.00 vs. DODFX (17.00). JPVRX has a lower initial minimum investment than DODFX: JPVRX (0) vs DODFX (2500). JPVRX annual gain was more profitable for investors over the last year : 30.68 vs. DODFX (26.68). DODFX return over 5 years is better than : 100.54 vs. JPVRX (89.07).
DODFXJPVRXDODFX / JPVRX
Total Expense Ratio0.610.6594%
Annual Report Gross Expense Ratio0.610.8076%
Fund Existence25 years10 years-
Gain YTD11.7869.500124%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets65.2B3.63B1,796%
Annual Yield % from dividends2.202.7181%
Returns for 1 year26.6830.6887%
Returns for 3 years96.38100.6796%
Returns for 5 years100.5489.07113%
Returns for 10 years229.74N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NHPBP22.090.04
+0.18%
National Healthcare Properties Inc
RAMP37.58N/A
N/A
LiveRamp Holdings
MCHX1.64-0.03
-1.80%
Marchex
OCGN1.34-0.03
-2.19%
Ocugen
AXSM222.16-8.09
-3.51%
Axsome Therapeutics